0001209191-22-032172.txt : 20220526
0001209191-22-032172.hdr.sgml : 20220526
20220526161000
ACCESSION NUMBER: 0001209191-22-032172
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220524
FILED AS OF DATE: 20220526
DATE AS OF CHANGE: 20220526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knobil Katharine
CENTRAL INDEX KEY: 0001768011
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37939
FILM NUMBER: 22970028
MAIL ADDRESS:
STREET 1: C/O KALEIDO BIOSCIENCES, INC.
STREET 2: 65 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Marker Therapeutics, Inc.
CENTRAL INDEX KEY: 0001094038
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880277072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3200 SOUTHWEST FREEWAY
STREET 2: SUITE 2500
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: (713) 400-6400
MAIL ADDRESS:
STREET 1: 3200 SOUTHWEST FREEWAY
STREET 2: SUITE 2500
CITY: HOUSTON
STATE: TX
ZIP: 77027
FORMER COMPANY:
FORMER CONFORMED NAME: TAPIMMUNE INC.
DATE OF NAME CHANGE: 20170629
FORMER COMPANY:
FORMER CONFORMED NAME: TAPIMMUNE INC
DATE OF NAME CHANGE: 20070628
FORMER COMPANY:
FORMER CONFORMED NAME: GENEMAX CORP
DATE OF NAME CHANGE: 20020718
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-24
0
0001094038
Marker Therapeutics, Inc.
MRKR
0001768011
Knobil Katharine
C/O MARKER THERAPEUTICS, INC.
3200 SOUTHWEST FREEWAY, SUITE 2500
HOUSTON
TX
77027
1
0
0
0
Stock Option (Right to Buy)
0.3377
2022-05-24
4
A
0
80000
0.00
A
2032-05-23
Common Stock
80000
80000
D
This option vests on May 24, 2023, subject to the Reporting Person's continued service as a director through the vesting date.
/s/ Michael Loiacono, Attorney-in-Fact
2022-05-26